Speaker Information
Speaker Bios
 |
Daniel LeeChief Executive Officer, Aperion BiologicsDaniel R. Lee is Aperion Biologics' Chief Executive Officer and has over 20 years experience in the medical device industry. Aperion Biologics, Inc., headquartered in San Antonio, Texas, is a venture-backed, clinical-stage medical device company addressing the significant need for an alternative to human-based sources of tissues to be used in surgical procedures.Aperion's lead product candidate, Z-Lig, is a patent-protected porcine tendon currently in human clinical development for use as an anterior cruciate ligament (ACL) replacement. Prior to joining CrossCart in August 2008, Danny was responsible for the TRUREPAIR business unit at Smith & Nephew Endoscopy (SNE). This business unit was a result of Smith & Nephew's acquisition of OsteoBiologics, Inc. (OBI) in July 2006 for $72.3 million. At OBI, Danny was responsible for global marketing activities at this early development organization focused on cartilage and bone repair technologies. Prior to joining OBI, Danny was the Director of Marketing for Regeneration Technologies, Inc (RTI), a leading allograft tissue processor for orthopedic, spinal, craniofacial, and urologic surgical applications which went public in 2000. While at RTI, Danny played a key role in creating and establishing RTI’s Sports Medicine business unit. Danny spent the first ten years of his career in research and development with the U.S. Surgical Corporation (now Covidien). Prior to joining RTI, he was the Director of the Sports Medicine Research and Development group at Surgical Dynamics, a subsidiary of U.S. Surgical Corporation. Much of his experience at U.S. Surgical focused on using resorbable materials for orthopedic products. Mr. Lee received his Bachelor of Science degree in Materials Science and Engineering from the Johns Hopkins University in 1983 and his Master of Science in Biomedical Engineering from the University of Alabama at Birmingham in 1988. He is a member of the Society for Biomaterials and the American Association of Tissue Banks (AATB) where he holds a Certified Tissue Bank Specialist (CTBS) certification. He currently holds eleven patents on implants and instruments used in orthopedic and general surgery. |
